Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caitriona Ryan

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|September 15, 2016
Psoriasis and cardiovascular disordersJillian Frieder, Caitriona Ryan
Lancet (London, England)|August 16, 2014
Ponesimod--a future oral therapy for psoriasis?Caitriona Ryan, Alan Menter
Dermatologic Clinics|November 22, 2014
Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbiditiesCaitriona Ryan, Brian Kirby
American Journal of Clinical Dermatology|July 18, 2019
Genital Psoriasis: Impact on Quality of Life and Treatment OptionsAine Kelly, Caitriona Ryan
Expert Opinion on Investigational Drugs|August 21, 2015
An overview of developing TNF-α targeted therapy for the treatment of psoriasisMolly Campa, Caitriona Ryan, Alan Menter
Arthritis|December 5, 2012
Psoriatic arthritis: an updatePeter Lloyd, Caitriona Ryan, Alan Menter
Journal of the American Academy of Dermatology|November 25, 2010
The use of cyclosporine in dermatology: part IICaitriona Ryan, Karrie T Amor, Alan Menter
Molecular Diagnosis & Therapy|April 3, 2010
The latest advances in pharmacogenetics and pharmacogenomics in the treatment of psoriasisCaitriona Ryan, Alan Menter, Richard B Warren
Journal of the American Academy of Dermatology|November 25, 2010
The use of cyclosporine in dermatology: part IKarrie T Amor, Caitriona Ryan, Alan Menter
Journal of the American Academy of Dermatology|September 16, 2014
The use of tumor necrosis factor inhibitors in pregnancy: what is the evidence?Dario Nicolas Kivelevitch, Caitriona Ryan, Alan Menter
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|September 15, 2016
Psoriasis and cardiovascular disordersJillian Frieder, Caitriona Ryan
Lancet (London, England)|August 16, 2014
Ponesimod--a future oral therapy for psoriasis?Caitriona Ryan, Alan Menter
Dermatologic Clinics|November 22, 2014
Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbiditiesCaitriona Ryan, Brian Kirby
American Journal of Clinical Dermatology|July 18, 2019
Genital Psoriasis: Impact on Quality of Life and Treatment OptionsAine Kelly, Caitriona Ryan
Expert Opinion on Investigational Drugs|August 21, 2015
An overview of developing TNF-α targeted therapy for the treatment of psoriasisMolly Campa, Caitriona Ryan, Alan Menter
Arthritis|December 5, 2012
Psoriatic arthritis: an updatePeter Lloyd, Caitriona Ryan, Alan Menter
Journal of the American Academy of Dermatology|November 25, 2010
The use of cyclosporine in dermatology: part IICaitriona Ryan, Karrie T Amor, Alan Menter
Molecular Diagnosis & Therapy|April 3, 2010
The latest advances in pharmacogenetics and pharmacogenomics in the treatment of psoriasisCaitriona Ryan, Alan Menter, Richard B Warren
Journal of the American Academy of Dermatology|November 25, 2010
The use of cyclosporine in dermatology: part IKarrie T Amor, Caitriona Ryan, Alan Menter
Journal of the American Academy of Dermatology|September 16, 2014
The use of tumor necrosis factor inhibitors in pregnancy: what is the evidence?Dario Nicolas Kivelevitch, Caitriona Ryan, Alan Menter
Pageof 5